ArticleNeuro-oncology2006

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma.

Michael D Prados et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.